Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...

Bibliografski detalji
Glavni autori:	Morgan, R, O'Callaghan, J, Knight, SR, Morris, P
Format:	Journal article
Jezik:	English
Izdano:	2012

Slični predmeti

Systematic reviews of alemtuzumab in renal transplantation.
od: O'Callaghan, J, i dr.
Izdano: (2013)

Systematic reviews of alemtuzumab in renal transplantation
od: O'Callaghan, J, i dr.
Izdano: (2013)

Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
od: O'Callaghan, J, i dr.
Izdano: (2013)

Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
od: O'Callaghan, J, i dr.
Izdano: (2012)

Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
od: O'Callaghan, J, i dr.
Izdano: (2012)

ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION
od: Muthusamy, A, i dr.
Izdano: (2011)

Systematic review of clinical practice guidelines in kidney transplantation
od: O'Donoghue, K, i dr.
Izdano: (2017)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
od: Watson, C, i dr.
Izdano: (2005)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
od: Haynes, R, i dr.
Izdano: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
od: Haynes, R, i dr.
Izdano: (2014)

Alemtuzumab induction and steroid free immunosupprssion in pancreas transplantation.
od: Muthusamy, A, i dr.
Izdano: (2007)

Critical appraisal of United Kingdom clinical practice guidelines in kidney transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: A systematic review
od: Knight, S, i dr.
Izdano: (2017)

The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis.
od: OʼCallaghan, J, i dr.
Izdano: (2014)

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
od: Muthusamy, A, i dr.
Izdano: (2008)

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction
od: Muthusamy, A, i dr.
Izdano: (2007)

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation
od: A. Benazzo, i dr.
Izdano: (2022-04-01)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
od: Martina Guthoff, i dr.
Izdano: (2020-05-01)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
od: Flechner, S, i dr.
Izdano: (2005)

Terapia de indução com alentuzumabe em receptores de transplante renal Alemtuzumab induction in kidney transplant recipients
od: Edison Luiz Mandia Sampaio, i dr.
Izdano: (2010-03-01)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
od: Haynes, R, i dr.
Izdano: (2014)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
od: Lukas K. van Vugt, i dr.
Izdano: (2023-11-01)

Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
od: A Khalafi-Nezhad, i dr.
Izdano: (2015-10-01)

A national registry analysis of kidney allografts preserved with Marshall's Solution in the United Kingdom
od: O'Callaghan, J, i dr.
Izdano: (2015)

Kidney transplantation--the long term view.
od: O'Callaghan, C
Izdano: (2008)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
od: Plata-Munoz, J, i dr.
Izdano: (2009)

Evidence based hypothermic preservation of the kidney and liver for transplantation
od: O'Callaghan, JM
Izdano: (2014)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
od: Masashi Furukawa, i dr.
Izdano: (2022-06-01)

The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis
od: Marco Puthenparampil, i dr.
Izdano: (2025-01-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
od: Adil S. Lakha, i dr.
Izdano: (2024-08-01)

Low incidence of lymphoproliferative disease post kidney transplantation with prevalent use of alemtuzumab
od: John Fredy Nieto-Ríos, i dr.
Izdano: (2014-01-01)

Transplant Trial Watch
od: John Matthew O’Callaghan, i dr.
Izdano: (2023-09-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
od: Lakha, AS, i dr.
Izdano: (2024)

Critical appraisal of International Clinical Practice Guidelines in Kidney Transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: a systematic review
od: O'Donoghue, K, i dr.
Izdano: (2018)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
od: Naoki Okada, i dr.
Izdano: (2023-08-01)

Transplant Trial Watch
od: John M. O’Callaghan, i dr.
Izdano: (2025-01-01)

Transplant Trial Watch
od: John M. O’Callaghan, i dr.
Izdano: (2024-07-01)

Transplant Trial Watch
od: John M. O’Callaghan, i dr.
Izdano: (2024-09-01)

Transplant Trial Watch
od: Simon R. Knight, i dr.
Izdano: (2024-10-01)

Transplant Trial Watch
od: Simon R. Knight, i dr.
Izdano: (2024-02-01)

Transplant Trial Watch
od: John M. O’Callaghan, i dr.
Izdano: (2024-01-01)